drugset / Trial / NCT00185510

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

NCT00185510

Phase 4 Completed 250 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Purpose of the study: One bothering feature of atopic dermatitis is its relapsing nature. Hence, it is worthwhile to test modes how to efficiently prevent relapses or at least increase the time until the disease recurs. In order to give recommendations to other patients, this study is to scientifically describe efficacy and safety of a given regimen, namely a maintenance therapy with two days a week Advantan.

Timeline

Start
2005-03
Primary completion
2006-05
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject methylprednisolone aceponate Small molecule Topical

Indications